2026-04-08T11:42:00-05:00 2025-12-31 991856619 GRANT THORNTON ADVISORS LLC 757 THIRD AVENUE 9TH FLOOR NEW YORK NY 100172013 990PF 2025-01-01 463285474 CLINICAL RESEARCH ASSOCIATES LLC CLIN 6466540066 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 MARLOW KEE TREASURER 6466540066 2026-04-08 1 SCOTT THOMPSETT P00741490 2125990100 2025 2025-03-06 01:10:19Z X X X 0 X 1274230 2664 2664 2664 0 0 1276894 2664 2664 0 0 0 0 466636 0 0 466636 140805 0 0 140805 254066 0 0 274362 4934 0 0 4934 1396 0 0 1570 18178 0 0 18178 4056 0 0 4056 1349162 2664 2664 737108 2239233 2664 2664 1647649 158739 158739 2397972 2664 2664 1806388 -1121078 0 0 473841 112436 629078 154690 0 0 1370045 0 0 197067 51900 0 248967 0 X 1121078 0 1121078 0 1370045 0 1121078 -1121078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 DE NY 1 1 0 0 0 1 N/A MARLOW KEE 6466540066 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 KELSEY MARTIN 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 PRESIDENT/MANAGER 1.00 0 0 0 DAVID SPERGEL 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 CHAIRPERSON/MANAGER 1.00 0 0 0 EUAN ROBERTSON 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 VICE PRESIDENT/MANAGER 1.00 0 0 0 MARLOW KEE 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 TREASURER/MANAGER 1.00 0 0 0 BRETT DAKIN 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 SECRETARY 1.00 0 0 0 KAREN WALTON-BOWEN 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 DIRECTOR OF CLINICAL 40.00 337505 31021 0 PAUL WANG 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 SENIOR DIRECTOR OF C 24.00 129131 38622 0 0 PEACHTREE BIORESEARCH SOLUTIONS 4985 LOWER ROSWELL RD BLDG 100 MARIETTA GA 30068 CLINICAL RESEARCH 360316 COOLEY LLP 3 EMBARCADERO CENTER 20TH FLR SAN FRANCISCO CA 94111 LEGAL 265056 PROMETRIKA LLC 100 CAMBRIDGE PARK DR 2ND FLR CAMBRIDGE MA 02140 META-DATA ANALYSIS 64811 0 AUTISM RESEARCH - CRA'S IMMEDIATE AIM IS TO EVALUATE ARBACLOFEN (R-BACLOFEN, STX209), AN EXPERIMENTAL MEDICATION, AS A POTENTIAL THERAPY IN ASD AND RELATED CONDITIONS. 1573032 0 0 269368 0 269368 0 0 269368 4041 265327 13266 X 1806388 0 1806388 2015-07-27 X 0 0 4965 1124 6089 0 0 4220 955 5176 1806388 4171808 3284681 2091505 11354382 158739 200000 0 0 358739 1647649 3971808 3284681 2091505 10995643 0 0 8844 26360 20830 18835 74869 0 0 0 0 X AUTISM SCIENCE FOUNDATION 106 WEST 32ND 182 NEW YORK NY 10001 N/A PC AUTISM RESEARCH 158739 158739 0 14 2664 0 2664 0 2664 0 0 0 0 0 0 0 0 0 0 X X 1 THE SIMONS FOUNDATION 160 FIFTH AVENUE 7TH FLOOR NEW YORK NY 10010 1274230 X TAX PREPARATION FEES 4934 0 0 4934 AUTISM SCIENCE FOUNDATION 106 WEST 32ND 182 NEW YORK NY 10001 CLINICAL RESEARCH ASSOCIATES, LLC'S REMAINING ASSETS CONSISTED SOLELY OF CASH TOTALING $158,739, WHICH WAS TRANSFERRED TO THE AUTISM SCIENCE FOUNDATION, A 501(C)(3) PUBLIC CHARITY, ON DECEMBER 31, 2025 NO OTHER ASSETS WERE AVAILABLE FOR DISTRIBUTION. 158739 PART I, LINE 23 & PART II, LINES 8 & 15 ASSETS WRITE-OFF PATENT AMORTIZATION EXPENSEDATE ACQUIRED 1/1/2014PATENT ORIGINAL VALUE $1,000,000 2025 AMORTIZATION $(49,310) DEDUCTION IN PRIOR YEARS $(845,310) ------------TOTAL AMORTIZATION $(894,620) ------------LOSS ON DISPOSAL OF ASSETS $(105,380) ------------PATENT NET VALUE $0INVENTORY WRITE-OFFINVENTORY AS OF 07/31/25 $629,078INVENTORY WRITE-OFF $(629,078) ------------INVENTORY NET VALUE $0STATEMENT REGARDING ASSETS WRITE-OFFAS OF AUGUST 1, 2025, THE REMAINING NET BOOK VALUE OF THE PATENT WAS $105,380 AND THE ASSOCIATED INVENTORY BALANCE WAS $629,078. MANAGEMENT DETERMINED THAT NEITHER THE PATENT, WHICH HAD BEEN REPORTED AS AN INTANGIBLE ASSET (R&D) ON FORM 990-PF, NOR THE RELATED INVENTORY HAD ANY REMAINING BOOK VALUE OR REALIZABLE FAIR MARKET VALUE. BASED ON THE HIGHLY SPECIALIZED NATURE OF THE DRUG, THE ABSENCE OF AN ACTIVE MARKET, THE LACK OF INTERESTED BUYERS, AND THE EXPECTATION THAT NO FUTURE ECONOMIC BENEFITS WOULD BE REALIZED FROM THESE ASSETS, THE CARRYING AMOUNTS WERE WRITTEN DOWN TO ZERO, RESULTING IN A LOSS ON DISPOSAL OF ASSETS OF $734,458. THIS STATEMENT IS PROVIDED PURSUANT TO TREASURY REGULATION 1.6043-3(A)(1) AND THE GENERAL INSTRUCTIONS TO FORM 990-PF TO DISCLOSE THE DISTRIBUTION OF ASSETS RESULTING FROM THE COMPLETE LIQUIDATION AND DISSOLUTION OF CLINICAL RESEARCH ASSOCIATES, LLC DURING THE TAXABLE YEAR ENDED DECEMBER 31, 2025. DURING 2025, CLINICAL RESEARCH ASSOCIATES, LLC MADE ONE DISTRIBUTION OF ASSETS IN CONNECTION WITH ITS COMPLETE LIQUIDATION. THIS DISTRIBUTION REPRESENTED 100% OF CLINICAL RESEARCH ASSOCIATES, LLC'S NET ASSETS AS MEASURED BY FAIR MARKET VALUE AS OF DECEMBER 31, 2025. INFORMATION REGARDING THE DISTRIBUTION IS AS FOLLOWS: CLINICAL RESEARCH ASSOCIATES, LLC WAS A WHOLLY OWNED SUBSIDIARY OF THE SIMONS FOUNDATION, INC, A NOT-FOR-PROFIT ORGANIZATION DESCRIBE IN SECTION 501(C)(3) AND CLASSIFIED AS A PRIVATE FOUNDATION. EFFECTIVE AUGUST 1, 2025, THE SIMONS FOUNDATION, INC. ASSUMED RESPONSIBILITY FOR ALL EXISTING AGREEMENTS, CONTRACTS, ASSETS, AND LIABILITIES OF CLINICAL RESEARCH ASSOCIATES, LLC, IN ORDER TO ENSURE THAT SUCH ASSETS AND LIABILITIES WERE DISTRIBUTED AND ADMINISTERED IN ACCORDANCE WITH APPLICABLE LEGAL AND REGULATORY REQUIREMENTS. CLINICAL RESEARCH ASSOCIATES, LLC RETAINED FULL KNOWLEDGE OF ITS OUTSTANDING LIABILITIES AND COMPLETED THE TRANSFER OF ITS ASSETS, AND ALL KNOWN LIABILITIES WERE SATISFIED OR OTHERWISE RESOLVED, PRIOR TO ITS FORMAL DISSOLUTION. CLINICAL RESEARCH ASSOCIATES, LLC CEASED ALL OPERATIONS AS OF DECEMBER 31, 2025. CLINICAL RESEARCH ASSOCIATES, LLC'S REMAINING ASSETS CONSISTED SOLELY OF CASH TOTALING $158,739, WHICH WAS TRANSFERRED TO THE AUTISM SCIENCE FOUNDATION, A 501(C)(3) PUBLIC CHARITY, ON DECEMBER 31, 2025, NO OTHER ASSETS WERE AVAILABLE FOR DISTRIBUTION. ON JANUARY 6, 2026, CRA WAS ISSUED A CERTIFICATE OF CANCELLATION BY THE STATE OF DELAWARE PURSUANT TO SECTION 18-801(2) OF THE DELAWARE LIMITED LIABILITY COMPANY ACT, FORMALLY COMPLETING ITS DISSOLUTION AND WINDING UP OF AFFAIRS EFFECTIVE DECEMBER 31, 2025. COOLEY LLP 244760 0 0 265056 FOX ROTHSCHILD LLP 7878 0 0 7878 LOEB, BLOCK & PARTNERS LLP 1428 0 0 1428 INTANGIBLE ASSET (R&D) 154690 0 0 DIRECT PROGRAM 293227 0 0 308536 PHARMACEUTICAL RESEARCH 205767 0 0 366943 CLINICAL TRIAL INSURANCE 16320 0 0 16320 INFORMATION TECHNOLOGY 8147 0 0 8591 ADMINISTRATIVE 40172 2664 2664 34845 EMPLOYEE DEVELOPMENT 1761 0 0 1873 PATENT AMORTIZATION 49310 0 0 0 LOSS ON DISPOSAL OF ASSETS 734458 0 0 0 DUE TO THE SIMONS FOUNDATION 51900 0 HUMAN RESOURCES CONSULTING 1090 0 0 1264 MISC. PROFESSIONAL SERVICES 306 0 0 306